1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Electrodiagnosis in cancer
    Book Section

    Ibanez, K.; Custodio, C. M.
    In Stubblefield, M. D. (Eds.) Cancer Rehabilitation: Principles and Practice. 2nd ed (2018)

    Fulltext@MSK | Save
  • Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma
    Conference Paper

    Yu, K.
    Millennium Medical Publishing, Inc (2018)

    Fulltext@MSK | Save
  • Informing, reassuring, or alarming? Balancing patient needs in the development of a postsurgical symptom reporting system in cancer
    Conference Paper

    Ancker, J. S.; Stabile, C.; Carter, J.; Chen, L. Y.; Stein, D.; Stetson, P. D.; Vickers, A. J.; Simon, B. A.; Temple, L. K.; Pusic, A. L.
    American Medical Informatics Association (2018)

    Fulltext@MSK | Save
  • Crowd counting with fully convolutional neural network
    Conference Paper

    Liu, M.; Jiang, J.; Guo, Z.; Wang, Z.; Liu, Y.
    IEEE (2018)

    Fulltext@MSK | Save
  • Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
    Journal Article

    Kumar, A.; Vardhana, S.; Moskowitz, A. J.; Porcu, P.; Dogan, A.; Dubovsky, J. A.; Matasar, M. J.; Zhang, Z.; Younes, A.; Horwitz, S. M.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • The first clinical/translational data from the expansion cohorts of a Ph1/1b study of IPI-549, a tumor macrophage-reprogramming small molecule, in combination with nivolumab in advanced solid tumors
    Meeting Abstract

    Chmielowski, B.; Sullivan, R. J.; Postow, M.; Patnaik, A.; Shapiro, G.; Cohen, E.; Gutierrez, M.; Steuer, C.; Ribas, A.; Lee, L.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project
    Meeting Abstract

    Fabrizio, D.; Chen, S. J.; Xie, M.; Chen, W.; Quin, K. J.; Zhao, C.; Zehir, A.; Funari, V.; Dickey, J. S.; Gupta, V.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; El Asmar, M.; Caushi, J.; Anagnostou, V.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; Naidoo, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444
    Meeting Abstract

    Fong, L.; Fong, L.; Powderly, J.; Luke, J.; Hotson, D.; Sznol, M.; George, S.; Choueiri, T.; Rini, B.; Hellmann, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save